Technical Analysis for ATNM - Actinium Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 8.26 -1.90% -0.16
ATNM closed down 1.9 percent on Wednesday, June 16, 2021, on 1.47 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
Historical ATNM trend table...

Date Alert Name Type % Chg
Overbought Stochastic Strength 0.00%
Weak + Overbought Other -1.90%
Outside Day Range Expansion -1.90%
Overbought Stochastic Strength -1.90%
Overbought Stochastic Strength -3.39%
Up 3 Days in a Row Strength -3.39%
Narrow Range Bar Range Contraction -2.94%
Overbought Stochastic Strength -2.94%
180 Bullish Setup Bullish Swing Setup -2.59%
Narrow Range Bar Range Contraction -2.59%
Older End-of-Day Signals for ATNM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Support about 4 hours ago
Down 3% about 5 hours ago
Trending on StockTwits about 6 hours ago
Down 2 % about 7 hours ago
Down 1% about 7 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Actinium Pharmaceuticals, Inc. Description

Actinium Pharmaceuticals, Inc., formerly Cactus Ventures, Inc. is a biopharmaceutical company developing cancer drugs. The Company's advanced products are Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), in human clinical trials for acute myeloid leukemia (AML) and Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used in myeloconditioning for hematopoietic stem cells transplantation (HSCT) in various indications. In addition, the Ac-225 based drugs development relies on the patented Alpha Particle Immunotherapy Technology (APIT) platform technology co-developed with Memorial Sloan- Kettering Cancer Center (MSKCC), a related institution. The APIT technology couples monoclonal antibodies (mAb) with extremely potent but comparatively safe alpha particle emitting radioactive isotopes, in particular actinium 225 and bismuth 213.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immunology Immunotherapy Natural Sciences Antibodies Monoclonal Antibody Monoclonal Antibodies Chemical Elements Stem Cells Acute Myeloid Leukemia Platform Technology Transplantation Hematopoietic Stem Cell Cancer Center Actinides Bismuth Iodine Cactus Immunotherapy Technology Kettering Cancer Center Memorial Sloan

Is ATNM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.47
52 Week Low 6.84
Average Volume 184,472
200-Day Moving Average 9.11
50-Day Moving Average 7.80
20-Day Moving Average 8.13
10-Day Moving Average 8.45
Average True Range 0.36
ADX 29.14
+DI 24.54
-DI 12.74
Chandelier Exit (Long, 3 ATRs) 7.73
Chandelier Exit (Short, 3 ATRs) 8.16
Upper Bollinger Bands 8.98
Lower Bollinger Band 7.28
Percent B (%b) 0.58
BandWidth 20.87
MACD Line 0.21
MACD Signal Line 0.20
MACD Histogram 0.013
Fundamentals Value
Market Cap 112.22 Million
Num Shares 13.6 Million
EPS -0.19
Price-to-Earnings (P/E) Ratio -43.94
Price-to-Sales 0.00
Price-to-Book 3.11
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.87
Resistance 3 (R3) 8.89 8.72 8.77
Resistance 2 (R2) 8.72 8.56 8.70 8.73
Resistance 1 (R1) 8.49 8.47 8.40 8.46 8.70
Pivot Point 8.31 8.31 8.27 8.30 8.31
Support 1 (S1) 8.08 8.16 8.00 8.06 7.82
Support 2 (S2) 7.91 8.06 7.89 7.79
Support 3 (S3) 7.68 7.91 7.75
Support 4 (S4) 7.65